An interventional study of Cognitive therapy and Behavioral therapy in Anxiety, Anxiety Acute and Anxiety Chronic, sponsored by Ohio State University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-19.
Sponsored by Ohio State University · Not applicable, Interventional, and Treatment
The purposes of this study are: (1) to identify baseline predictors of relative success in cognitive, behavioral, and mindfulness-based treatments for anxiety, (2) explore who benefits from a brief, video-based skill training compared to receiving 4 sessions of therapy, and (3) to evaluate how durable these effects are over 1 year.
7,201 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.
This study's planned enrollment of 600 is above the median of 80 across 6,057 interventional studies indexed under Anxiety Disorders.
Browse Anxiety Disorders studies →Ohio State University is the lead sponsor of 663 studies on the registry; 148 are open to participants now.
Of its 67 completed or terminated interventional studies of FDA-regulated products, 49 (73%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Cognitive therapy
Behavioral: Behavioral therapy
Behavioral: Mindfulness-based therapy
Cognitive therapy involves identifying and challenging negative automatic thoughts.
Behavioral therapy involves identifying emotional urges and acting opposite to those urges.
Mindfulness-based therapy involves cultivating nonjudgmental present-moment awareness of thoughts, feelings, and behaviors.
Overall Anxiety Severity and Impairment Scale (OASIS)
Minimum value: 0. Maximum value = 20. High scores mean worse outcomes.
Time frame: Weekly for 6 weeks, then monthly for 1 year.
Overall Depression Severity and Impairment Scale (ODSIS)
Minimum = 0. Maximum = 20. Higher scores mean worse outcomes.
Time frame: Weekly for 6 weeks, then monthly for 1 year.
Plan to share: Undecided — We plan to share participants' condition and primary and secondary outcome data, although, given the ending of Open Science Framework support for this sharing, we are undecided about where and how we will share this data.
Started Oct 2025 (actual). Primary completion is estimated for Aug 2029, 46 months after the start.
Of 3,836 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 46 months is above that.
Counting every sponsor, half of 3,938 studies reached it within 12 months; a quarter within 5 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.